Institutional Manager · CIK 0001622627
Rosalind Advisors, Inc.
TORONTO, A6 · File #028-23857
Latest AUM
$284.5M
Positions
42
Top-10 Concentration
60.7%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | REZOLUTE INC | 76200L309 | -1,807,202 | -$17.0M | $0 |
| NEW | REPLIMUNE GROUP INC | REPL | +1,410,497 | +$13.7M | $0 |
| REDUCE | CYTOKINETICS INC | CYTK | -204,955 | -$13.0M | +$3.4M |
| EXITED | VERONA PHARMA PLC | 925050106 | -100,000 | -$10.7M | $0 |
| REDUCE | FRACTYL HEALTH INC | GUTS | -4,614,269 | -$10.2M | +$3.0M |
| EXITED | IDEAYA BIOSCIENCES INC | 45166A102 | -350,000 | -$9.5M | $0 |
| EXITED | UNIQURE NV | N90064101 | -125,000 | -$7.3M | $0 |
| REDUCE | VIRIDIAN THERAPEUTICS INC | VRDN | -150,000 | -$4.7M | +$5.7M |
| EXITED | ATYR PHARMA INC | 002120952 | -1,570,200 | -$4.5M | $0 |
| NEW | ARRIVENT BIOPHARMA INC | AVBP | +215,871 | +$4.3M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202542 pos · $284.5M
- 13F HOLDINGS REPORTQ/E Sep 202539 pos · $292.6M
- 13F HOLDINGS REPORTQ/E Jun 202537 pos · $210.9M
- 13F HOLDINGS REPORTQ/E Mar 202534 pos · $205.6M
- 13F HOLDINGS REPORT (Amended)Q/E Dec 202440 pos · $195.6M
- 13F HOLDINGS REPORTQ/E Dec 202440 pos · $195.6M
- 13F HOLDINGS REPORTQ/E Sep 202433 pos · $156.2M
- 13F HOLDINGS REPORTQ/E Jun 202440 pos · $130.0M
- 13F HOLDINGS REPORTQ/E Mar 202434 pos · $107.0M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | DELCATH SYSTEMS, INC. | DCTH | 3,300,389 | $33.0M | 11.60% |
| 2 | SAVARA INC | SVRA | 3,403,721 | $20.5M | 7.21% |
| 3 | FENNEC PHARMACEUTICALS INC | FENC | 2,613,508 | $20.1M | 7.07% |
| 4 | XERIS BIOPHARMA HOLDGS INC | XERS | 2,111,700 | $16.6M | 5.83% |
| 5 | VIRIDIAN THERAPEUTICS INC | VRDN | 450,000 | $14.0M | 4.92% |
| 6 | MEDIWOUND LTD | MDWD | 749,054 | $13.8M | 4.86% |
| 7 | VERASTEM INC | VSTM | 1,788,475 | $13.8M | 4.85% |
| 8 | REPLIMUNE GROUP INC | REPL | 1,410,497 | $13.7M | 4.82% |
| 9 | ASTRIA THERAPEUTICS INC | ATYR | 1,039,080 | $13.6M | 4.78% |
| 10 | CYBIN INC | HELP | 1,657,540 | $13.6M | 4.77% |
| 11 | EYEPOINT PHARMACEUTICALS INC | EYPT | 690,000 | $12.6M | 4.43% |
| 12 | CG ONCOLOGY INC | CGON | 300,000 | $12.5M | 4.38% |
| 13 | CYTOKINETICS INC | CYTK | 195,045 | $12.4M | 4.36% |
| 14 | X4 PHARMACEUTICALS INC | XFOR | 2,605,920 | $10.4M | 3.66% |
| 15 | MIND MEDICINE MINDMED INC | 60255C885 | 750,000 | $10.0M | 3.53% |
| 16 | PROFOUND MEDICAL CORP | PROF | 1,068,955 | $8.4M | 2.96% |
| 17 | INSPIREMD INC | NSPR | 3,905,743 | $7.0M | 2.44% |
| 18 | Ocular Therapeutix, Inc | OCUL | 400,000 | $4.9M | 1.71% |
| 19 | ARRIVENT BIOPHARMA INC | AVBP | 215,871 | $4.3M | 1.53% |
| 20 | TALPHERA INC | TLPH | 3,579,273 | $4.1M | 1.43% |